FAM
RMD icon

Fairtree Asset Management’s ResMed RMD Stock Holding History

Fairtree Asset Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.63M Buy
13,498
+2,950
+28% +$611K 1.01% 24
2026
Q1 		$2.37M Buy
10,548
+2,128
+25% +$530K 1.09% 23
2025
Q4 		$2.03M Buy
8,420
+4,389
+109% +$1.12M 0.93% 30
2025
Q3 		$1.1M Buy
4,031
+1,222
+44% +$334K 0.72% 42
2025
Q2 		$725K Hold
2,809
– – 0.55% 58
2025
Q1 		$629K Buy
+2,809
New +$656K 0.51% 54

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Fairtree Asset Management's RMD Position: Q2 2026 in Review

Fairtree Asset Management increased its ResMed (RMD) stake by 28% in Q2 2026, buying an estimated $611K and bringing the position to 13,498 shares worth $2.63M. The position accounts for 1.01% of the portfolio, ranked #24.

Fairtree Asset Management first reported a position in RMD in Q1 2025 and has held it in 6 quarters since. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Fairtree Asset Management held 13,498 shares of ResMed worth $2.63M as of Q2 2026.
  • Fairtree Asset Management bought 2,950 ResMed shares in Q2 2026, an estimated $611K.
  • ResMed made up 1.01% of Fairtree Asset Management's portfolio in Q2 2026, its #24 holding.
  • Fairtree Asset Management first reported a position in ResMed in Q1 2025 and has held it in 6 quarters since.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Fairtree Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.